Societal CDMO(SCTL) - 2021 Q3 - Quarterly Report
Societal CDMOSocietal CDMO(US:SCTL)2021-11-09 21:13

FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36329 Recro Pharma, Inc. (Exact name of registrant as specified in its charter) Pennsylvania 26-1523233 (State or other jurisdiction of i ...